Intravenous Immunoglobulins Market 2017 Trend, Analysis and Forecast to 2021
ReportsWeb.com published “Intravenous Immunoglobulins Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, June 22, 2017 ) Immunoglobulins are glycoprotein molecules produced by plasma cells. They are a critical part of a body's immune response and they do so by specifically recognizing and binding to microbes and destroying them. These immunoglobulins are produced by a body naturally, but due to some genetic or infectious diseases, the natural production of immunoglobulin is inhibited, resulting in an immune-compromised condition.
Publisher’s analysts forecast the global intravenous immunoglobulins market to grow at a CAGR of 7.62% during the period 2017-2021.
For more information about this report: http://www.reportsweb.com/global-intravenous-immunoglobulins-market-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global intravenous immunoglobulins market for 2017-2021. To calculate the market size, the report considers sales from both generic and branded drugs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Publisher's report, Global Intravenous Immunoglobulins Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• CSL Behring
• Grifols
• Octapharma
• Shire
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001819120/sample .
Other prominent vendors
• ADMA Biologics
• Bayer
• Bharat Serum and Vaccines
• Biotest AG
• China Biologic Products
• Hualan Biological Engineering
• Kedrion Biopharma
• LFB Group
• Sanquin
Market driver
• Growing number of fractionating units
• For a full, detailed list, view our report
Market challenge
• Complex and cost-intensive manufacturing
• For a full, detailed list, view our report
Market trend
• Monetary support to plasma donors
• For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001819120/buying .
Publisher’s analysts forecast the global intravenous immunoglobulins market to grow at a CAGR of 7.62% during the period 2017-2021.
For more information about this report: http://www.reportsweb.com/global-intravenous-immunoglobulins-market-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global intravenous immunoglobulins market for 2017-2021. To calculate the market size, the report considers sales from both generic and branded drugs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Publisher's report, Global Intravenous Immunoglobulins Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• CSL Behring
• Grifols
• Octapharma
• Shire
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001819120/sample .
Other prominent vendors
• ADMA Biologics
• Bayer
• Bharat Serum and Vaccines
• Biotest AG
• China Biologic Products
• Hualan Biological Engineering
• Kedrion Biopharma
• LFB Group
• Sanquin
Market driver
• Growing number of fractionating units
• For a full, detailed list, view our report
Market challenge
• Complex and cost-intensive manufacturing
• For a full, detailed list, view our report
Market trend
• Monetary support to plasma donors
• For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001819120/buying .
Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results